These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34938106)

  • 21. N6-Methylandenosine-Related lncRNA Signature Is a Novel Biomarkers of Prognosis and Immune Response in Colon Adenocarcinoma Patients.
    Zhang P; Liu G; Lu L
    Front Cell Dev Biol; 2021; 9():703629. PubMed ID: 34336856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoxia Constructing the Prognostic Model of Colorectal Adenocarcinoma and Related to the Immune Microenvironment.
    Zhang Y; Yang F; Peng X; Li X; Luo N; Zhu W; Fu M; Li Q; Hu G
    Front Cell Dev Biol; 2021; 9():665364. PubMed ID: 33959617
    [No Abstract]   [Full Text] [Related]  

  • 23. Mining novel cell glycolysis related gene markers that can predict the survival of colon adenocarcinoma patients.
    Chen S; Cao G; Wu W; Lu Y; He X; Yang L; Chen K; Chen B; Xiong M
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32744303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of sixteen metabolic genes as potential biomarkers for colon adenocarcinoma.
    Zhao F; Liu Y; Gu X; Zhang B; Song C; Cui B
    J BUON; 2021; 26(4):1252-1259. PubMed ID: 34564978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel enterocyte-related 4-gene signature for predicting prognosis in colon adenocarcinoma.
    Cheng X; Wei Y; Fu Y; Li J; Han L
    Front Immunol; 2022; 13():1052182. PubMed ID: 36532007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. INSC Is Down-Regulated in Colon Cancer and Correlated to Immune Infiltration.
    Yu T; Li D; Zeng Z; Xu X; Zhang H; Wu J; Song W; Zhu H
    Front Genet; 2022; 13():821826. PubMed ID: 35664320
    [No Abstract]   [Full Text] [Related]  

  • 27. Identification and validation of a necroptosis-related gene prognostic signature for colon adenocarcinoma.
    Zhang J; Liu Z; Chen W; Liu H
    Transl Cancer Res; 2023 Sep; 12(9):2239-2255. PubMed ID: 37859737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel defined cuproptosis-related gene signature for predicting the prognosis of colon adenocarcinoma.
    Luo B; Lin J; Ni A; Cai W; Yu X; Wang M
    Front Oncol; 2022; 12():927028. PubMed ID: 36505872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. System analysis based on the ER stress-related genes identifies WFS1 as a novel therapy target for colon cancer.
    Yang X; Zhang C; Yan C; Ma L; Ma J; Meng X
    Aging (Albany NY); 2022 Nov; 14(22):9243-9263. PubMed ID: 36445321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microdissecting the Hypoxia Landscape in Colon Cancer Reveals Three Distinct Subtypes and Their Potential Mechanism to Facilitate the Development of Cancer.
    Tang P; Wu Y; Zhu C; Li Q; Liu S
    J Oncol; 2023; 2023():9346621. PubMed ID: 36925652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploration of Potential Roles of m5C-Related Regulators in Colon Adenocarcinoma Prognosis.
    Huang Y; Huang C; Jiang X; Yan Y; Zhuang K; Liu F; Li P; Wen Y
    Front Genet; 2022; 13():816173. PubMed ID: 35281843
    [No Abstract]   [Full Text] [Related]  

  • 32. Construction of a Prognostic Model Based on Methylation-Related Genes in Patients with Colon Adenocarcinoma.
    Liu Z; Xu Y; Jin S; Liu X; Wang B
    Cancer Manag Res; 2023; 15():1097-1110. PubMed ID: 37818334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Prognostic Model for Colon Adenocarcinoma Patients Based on Ten Amino Acid Metabolism Related Genes.
    Ren Y; He S; Feng S; Yang W
    Front Public Health; 2022; 10():916364. PubMed ID: 35712285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Novel Cancer Stemness-Related Signature for Predicting Prognosis in Patients with Colon Adenocarcinoma.
    Wang W; Xu C; Ren Y; Wang S; Liao C; Fu X; Hu H
    Stem Cells Int; 2021; 2021():7036059. PubMed ID: 34691191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive analysis of the correlation between GSTM1 and tumor immunity in colon cancer.
    Luo HY; Tang WL; Xiang L; Peng LL; Wu DB; Zhu ZY; Gu HT; Tang YH; Perkins RS; Shen HY; Wang YX
    J Gastrointest Oncol; 2022 Dec; 13(6):3025-3037. PubMed ID: 36636093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5mC-Related lncRNAs as Potential Prognostic Biomarkers in Colon Adenocarcinoma.
    Huang Y; Huang H; Wang Y; Liu H; Huang Y
    Biology (Basel); 2022 Feb; 11(2):. PubMed ID: 35205097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A New RBPs-Related Signature Predicts the Prognosis of Colon Adenocarcinoma Patients.
    Chang K; Yuan C; Liu X
    Front Oncol; 2021; 11():627504. PubMed ID: 33767995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of an exosome-related and immune microenvironment prognostic signature in colon adenocarcinoma.
    Cui G; Wang C; Liu J; Shon K; Gu R; Chang C; Ren L; Wei F; Sun Z
    Front Genet; 2022; 13():995644. PubMed ID: 36176299
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical Correlation of Wnt2 and COL8A1 With Colon Adenocarcinoma Prognosis.
    Zhang L; Jiang X; Li Y; Fan Q; Li H; Jin L; Li L; Jin Y; Zhang T; Mao Y; Hua D
    Front Oncol; 2020; 10():1504. PubMed ID: 32983993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma.
    Tan Y; Lu L; Liang X; Chen Y
    World J Surg Oncol; 2022 Apr; 20(1):118. PubMed ID: 35413978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.